CVE detail

CVE-2025-52653 — CVE-2025-52653

Published 2025-10-03 · Modified 2026-06-17 · Vendor hcltech · Product dryice_myxalytics · Source nvd

HIGH

severity

CVSS-derived band

7.6

CVSS v3

0–10 scale

0.0024

EPSS probability

exploitation probability, 30d

15.0%

EPSS percentile

percentile vs all CVEs

NOT LISTED

CISA KEV

known exploited catalog

Description

HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.

Remediation

No vendor-published fix data in our corpus for this CVE. Check the references below or the vendor's PSIRT / security advisories page.

References

cvedb.io · NVD · CISA KEV · FIRST EPSS · vendor advisories (CVE Program List v5). Informational only, no warranty — verify every remediation against the vendor advisory before acting on it. This product uses data from the NVD API but is not endorsed or certified by the NVD, CISA, FIRST.org or any vendor named. CVE® is a registered trademark of The MITRE Corporation.